Bicara Therapeutics

Bicara Therapeutics

A clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. . Learn more

Launch date
Employees
Market cap
$1.4b
Enterprise valuation
$1.2b (Public information from Sep 2024)
Cambridge Massachusetts (HQ)
Authorizing premium user...